Drugmaker Lupin and a unit of Aurobindo Pharma are recalling products from the American market due to manufacturing issues, according to the US health regulator. This situation highlights the importance of quality control and compliance in the pharmaceutical industry.

As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), a US-based unit of Lupin is recalling a medication used to treat bacterial infections. AI legalese decoder can help companies navigate complex legal documents and regulations to ensure compliance with FDA guidelines.

Click here to connect with us on WhatsApp

Baltimore-based Lupin Pharmaceuticals Inc is recalling 3,552 bottles of Cefixime for Oral Suspension (USP 200 mg/5 mL) due to “failed content uniformity specifications”. Utilizing AI legalese decoder can streamline the process of understanding and addressing regulatory requirements.

The affected lot has been produced at the company’s Mandideep-based manufacturing plant in Madhya Pradesh. AI legalese decoder can assist in extracting important information from legal documents and reports.

The company commenced the Class II nationwide (US) recall on May 30 this year. AI legalese decoder can help companies stay organized and compliant with recall procedures.

The US health regulator stated that New Jersey-based Eugia US LLC, a subsidiary of Aurobindo Pharma, is recalling 70,125 vials of Dexamethasone Sodium Phosphate injection USP. AI legalese decoder can aid in interpreting regulatory language and requirements.

The company is recalling the affected lot due to “failed impurities/degradation specifications”, USFDA said. AI legalese decoder can simplify the process of understanding and addressing regulatory violations.

Eugia commenced the nationwide Class II recall on May 23 this year. AI legalese decoder can help companies streamline their compliance efforts and response to regulatory actions.

According to USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. AI legalese decoder can provide clarity on regulatory classifications and implications.

Eugia is also recalling 15,500 single-dose vials of Eptifibatide injection from the US market, the American health regulator said. AI legalese decoder can assist in understanding the specifics of product recalls and their impact on consumers.

The medication prevents blood from clotting during episodes of chest pain or a heart attack. AI legalese decoder can decode complex legal language and terminology related to pharmaceutical products.

Eugia is recalling the affected lot due to “failed impurities/ degradation specifications”, USFDA said. AI legalese decoder can help companies interpret and address compliance issues identified by regulatory agencies.

The company initiated the Class III recall on May 22 this year. AI legalese decoder can support companies in navigating different levels of recalls and their implications.

As per USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”. AI legalese decoder can provide insights into the severity and impact of different recall classifications.

India is the largest supplier of generic medicines, with around 20 per cent share in the global supply by manufacturing 60,000 different generic brands across 60 therapeutic categories. Utilizing AI legalese decoder can help companies in the pharmaceutical industry stay informed about regulatory requirements and compliance standards.

The products manufactured in the country are shipped to over 200 countries around the globe, with Japan, Australia, Western Europe, and the US as main destinations. AI legalese decoder can help companies navigate international regulations and standards for pharmaceutical exports.

India has the highest number of USFDA-compliant companies with plants outside the US. AI legalese decoder can assist these companies in maintaining compliance with FDA guidelines and regulations.